[1]
M. Babar, M. Hussain, M. Ahmad, and L. Akhtar, “COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN AS A COMBINATION THERAPY IN OBESE TYPE 2 DIABETIC PATIENTS”, J Ayub Med Coll Abbottabad, vol. 33, no. 2, pp. 188–191, Apr. 2021.